Drug Discovery

share

The drug, which won approval in Europe in August last year, is an oral, once-daily, potent selective vascular...

share

A study conducted by the ICR revealed that colon cancer can be treated by combining drugs able to...

share

According to results from the Phase III PROSPER trial, Xtandi (enzalutamide) plus androgen deprivation therapy (ADT) slashed the...

share

Researchers at University College London have developed a spray to deliver soluble nanoparticles containing a natural opioid called...

share

Fexinidazole is a 10-day oral treatment under investigation for Trypanosoma brucei gambiense human African trypanosomiasis (g-HAT), a fatal...

share

The National Institutes of Health (NIH) has launched a partnership to advance the treatment of Parkinson’s disease. The...

share

It is hoped that the next round of procurement, which launches in February and is to be the...

share

LGS is a rare, lifelong form of epilepsy associated with a high mortality rate and significant developmental delays....